Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134736880> ?p ?o ?g. }
- W3134736880 abstract "We aimed to assess the prognostic value of repeated measurements of serum (1-3)-β-D-glucan (BDG), mannan-antigen (mannan-Ag), and antimannan antibodies (antimannan-Ab) for the occurrence of invasive candidiasis (IC) in a high-risk nonimmunocompromised population.This was a preplanned ancillary analysis of the EMPIRICUS Randomized Clinical Trial, including nonimmunocompromised critically ill patients with intensive care unit-acquired sepsis, multiple Candida colonization, and multiple organ failure who were exposed to broad-spectrum antibacterial agents. BDG (>80 and >250 pg/mL), mannan-Ag (>125 pg/mL), and antimannan-Ab (>10 AU) were collected repeatedly. We used cause-specific hazard models. Biomarkers were assessed at baseline in the whole cohort (cohort 1). Baseline covariates and/or repeated measurements and/or increased biomarkers were then studied in the subgroup of patients who were still alive at day 3 and free of IC (cohort 2).Two hundred thirty-four patients were included, and 215 were still alive and free of IC at day 3. IC developed in 27 patients (11.5%), and day 28 mortality was 29.1%. Finally, BDG >80 pg/mL at inclusion was associated with an increased risk of IC (CSHR[IC], 4.67; 95% CI, 1.61-13.5) but not death (CSHR[death], 1.20; 95% CI, 0.71-2.02).Among high-risk patients, a first measurement of BDG >80 pg/mL was strongly associated with the occurrence of IC. Neither a cutoff of 250 pg/mL nor repeated measurements of fungal biomarkers seemed to be useful to predict the occurrence of IC. The cumulative risk of IC in the placebo group if BDG >80 pg/mL was 25.39%, which calls into question the efficacy of empirical therapy in this subgroup." @default.
- W3134736880 created "2021-03-15" @default.
- W3134736880 creator A5011701464 @default.
- W3134736880 creator A5013290885 @default.
- W3134736880 creator A5026385940 @default.
- W3134736880 creator A5037587167 @default.
- W3134736880 creator A5039514260 @default.
- W3134736880 creator A5048562879 @default.
- W3134736880 creator A5051133004 @default.
- W3134736880 creator A5057058749 @default.
- W3134736880 creator A5076578951 @default.
- W3134736880 creator A5086380377 @default.
- W3134736880 date "2021-03-01" @default.
- W3134736880 modified "2023-10-17" @default.
- W3134736880 title "Performance of Repeated Measures of (1–3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial" @default.
- W3134736880 cites W1879723880 @default.
- W3134736880 cites W1965625796 @default.
- W3134736880 cites W1967075191 @default.
- W3134736880 cites W1969467869 @default.
- W3134736880 cites W1970856277 @default.
- W3134736880 cites W1988769774 @default.
- W3134736880 cites W1995153426 @default.
- W3134736880 cites W1999505707 @default.
- W3134736880 cites W2056588441 @default.
- W3134736880 cites W2069094767 @default.
- W3134736880 cites W2080363965 @default.
- W3134736880 cites W2105904660 @default.
- W3134736880 cites W2106858657 @default.
- W3134736880 cites W2141329212 @default.
- W3134736880 cites W2152509995 @default.
- W3134736880 cites W2154746519 @default.
- W3134736880 cites W2157070947 @default.
- W3134736880 cites W2159060053 @default.
- W3134736880 cites W2161019652 @default.
- W3134736880 cites W2163845781 @default.
- W3134736880 cites W2165158988 @default.
- W3134736880 cites W2216117396 @default.
- W3134736880 cites W2260819425 @default.
- W3134736880 cites W2296180935 @default.
- W3134736880 cites W2342990795 @default.
- W3134736880 cites W2373438064 @default.
- W3134736880 cites W2527881422 @default.
- W3134736880 cites W2592469854 @default.
- W3134736880 cites W2757748878 @default.
- W3134736880 cites W2782394839 @default.
- W3134736880 cites W2790020787 @default.
- W3134736880 cites W2896886822 @default.
- W3134736880 cites W2941512894 @default.
- W3134736880 cites W2970407094 @default.
- W3134736880 cites W2992250822 @default.
- W3134736880 cites W3008076556 @default.
- W3134736880 cites W3014976350 @default.
- W3134736880 cites W3025755896 @default.
- W3134736880 cites W3043852189 @default.
- W3134736880 cites W3046052155 @default.
- W3134736880 cites W3083123136 @default.
- W3134736880 cites W765271840 @default.
- W3134736880 doi "https://doi.org/10.1093/ofid/ofab080" @default.
- W3134736880 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8002176" @default.
- W3134736880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33816643" @default.
- W3134736880 hasPublicationYear "2021" @default.
- W3134736880 type Work @default.
- W3134736880 sameAs 3134736880 @default.
- W3134736880 citedByCount "10" @default.
- W3134736880 countsByYear W31347368802021 @default.
- W3134736880 countsByYear W31347368802022 @default.
- W3134736880 countsByYear W31347368802023 @default.
- W3134736880 crossrefType "journal-article" @default.
- W3134736880 hasAuthorship W3134736880A5011701464 @default.
- W3134736880 hasAuthorship W3134736880A5013290885 @default.
- W3134736880 hasAuthorship W3134736880A5026385940 @default.
- W3134736880 hasAuthorship W3134736880A5037587167 @default.
- W3134736880 hasAuthorship W3134736880A5039514260 @default.
- W3134736880 hasAuthorship W3134736880A5048562879 @default.
- W3134736880 hasAuthorship W3134736880A5051133004 @default.
- W3134736880 hasAuthorship W3134736880A5057058749 @default.
- W3134736880 hasAuthorship W3134736880A5076578951 @default.
- W3134736880 hasAuthorship W3134736880A5086380377 @default.
- W3134736880 hasBestOaLocation W31347368801 @default.
- W3134736880 hasConcept C100817775 @default.
- W3134736880 hasConcept C126322002 @default.
- W3134736880 hasConcept C159654299 @default.
- W3134736880 hasConcept C168563851 @default.
- W3134736880 hasConcept C201903717 @default.
- W3134736880 hasConcept C203014093 @default.
- W3134736880 hasConcept C207103383 @default.
- W3134736880 hasConcept C2776376669 @default.
- W3134736880 hasConcept C2778384902 @default.
- W3134736880 hasConcept C2779719659 @default.
- W3134736880 hasConcept C2908647359 @default.
- W3134736880 hasConcept C44249647 @default.
- W3134736880 hasConcept C535046627 @default.
- W3134736880 hasConcept C55493867 @default.
- W3134736880 hasConcept C71924100 @default.
- W3134736880 hasConcept C72563966 @default.
- W3134736880 hasConcept C86803240 @default.
- W3134736880 hasConcept C90924648 @default.
- W3134736880 hasConcept C99454951 @default.
- W3134736880 hasConceptScore W3134736880C100817775 @default.
- W3134736880 hasConceptScore W3134736880C126322002 @default.